Litcius/Paper detail

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Shiv Kumar Sarin, Ashok Choudhury, George Lau, Ming‐Hua Zheng, Dong Ji, Sherief Abd‐Elsalam, Jae-Seok Hwang, Xiaolong Qi, Ian Homer, Jeong Ill Suh, Jun Gi Park, Opass Putcharoen, Apichat Kaewdech, Teerha Piratvisuth, Sombat Treeprasertsuk, Soo Young Park, Salisa Wejnaruemarn, Diana A. Payawal, Oidov Baatarkhuu, Sang Hoon Ahn, Chang Dong Yeo, Uzziel Romar Alonzo, Tserendorj Chinbayar, Imelda Maria Loho, Osamu Yokosuka, Wasim Jafri, Soek-Siam Tan, Lau Ing Soo, Tawesak Tanwandee, Rino Alvani Gani, Lovkesh Anand, Eslam Saber Esmail, Mai Khalaf, Shahinul Alam, Chun‐Yu Lin, Wan‐Long Chuang, Arvinder S. Soin, Hitendra Garg, Kemal Fariz Kalista, Badamnachin Batsukh, Hery Djagat Purnomo, Vijay Pal Dara, Pravin Rathi, Mamun Al Mahtab, Akash Shukla, Manoj K. Sharma, Masao Omata, APASL COVID Task Force, APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640)

2020Hepatology International295 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHepatologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakInternal medicineColorectal surgeryLiver injuryGastroenterologyAbdominal surgeryDiseaseVirologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesCOVID-19 Impact on ReproductionLong-Term Effects of COVID-19
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) | Litcius